Knowledge Base • NCK Pharma

11 May 2021

DCGI – India approved anti-Covid drug 2-DG developed by DRDO for emergency use

Posted Byadmin

Comments0

Tags2-DG, Dr. Reddy’s Laboratories, DRDO, DRL

The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied...

11 May 2021

Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India

Posted Byadmin

Comments0

TagsBaricitinib, Cipla, Eli Lilly, Lupin, Sun Pharma

US drug-maker Eli Lilly, on May 10, announced that it had issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical...

28 Apr 2021

Case Study: Pfizer acquires Amplyx Pharmaceuticals

Posted Byadmin

Comments0

Tagsacquisition, acquisition in pharma, Fosmanogepix, pfizer, Pfizer's Acquisition of Anacor, pharma deal, Why Pfizer to acquire AM Pharma

Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s...

11 Feb 2021

Philips acquired US-based remote medical technology company, BioTelemetry

Posted Byadmin

Comments0

Royal Philips, a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc., a leading...

11 Feb 2021

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Posted Byadmin

Comments0

Tagsotenaproxesul

Antibe Therapeutics Inc. licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company...

11 Feb 2021

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

Posted Byadmin

Comments0

TagsEpidiolex, GW Pharma, Jazz Pharmaceuticals

GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW...

10 Feb 2021

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Posted Byadmin

Comments0

Tagsfostemsavir, HIV-1 attachment inhibitor, Rukobia, ViiV Healthcare

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc and Shionogi Limited as...

10 Feb 2021

Sanofi received additional indication approval for Plavix

Posted Byadmin

Comments0

Tagsadditional indication approval, plavix, Sanofi

European Commission (EC) has approved an additional indication for Plavix (clopidogrel) to include its use in combination with aspirin in...

10 Feb 2021

CoronaVac received conditional marketing authorization from NMPA China

Posted Byadmin

Comments0

Sinovac Biotech announced that the China National Medical Products Administration (NMPA) has granted a conditional marketing authorization (CMA) to Sinovac...

13 Jan 2021

What is the meaning of pharmaceutical profiling?

Posted Byadmin

Comments0

Tagspharmaceutical profiling

Pharmaceutical profiling assays helps to measure the properties of large numbers of drug candidates at the earliest stages of discovery....

13 Jan 2021

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Posted Byadmin

Comments0

TagsGlobalpharma sanofi, Kymab, monoclonal antibody, Sanofi

Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of...

1 Jan 2021

Covishield received emergency use authorization in India

Posted Byadmin

Comments0

TagsAstraZeneca, Covid vaccine, COVID-19, Covishield, serum institute

Covidshield vaccine, developed by AstraZeneca and Oxford University has received for emergency use authorization in India. Drugs Controller General of...

30 Dec 2020

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Posted Byadmin

Comments0

TagsGlenmark, PMT in pharma, Remogliflozin etabonate, vildagliptin

Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor...

30 Dec 2020

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

Posted Byadmin

Comments0

TagsMyovant, Orgovyx, pfizer, relugolix

Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the...

30 Dec 2020

Insight on Aurobindo and COVAXX exclusive licensing agreement

Posted Byadmin

Comments0

TagsAurobindo, COVAXX, Covid vaccine, COVID-19

Aurobindo and COVAXX, have entered into an Exclusive License Agreement to develop, commercialize and manufacture Covid-19 Vaccine. Aurobindo Pharma and...

29 Dec 2020

Pfizer, BioNTech covid vaccine approval tilldate

Posted Byadmin

Comments0

TagsCovid vaccine, COVID-19

Pfizer, BioNTech covid vaccine (BNT162b2) has received following marketing authorization* approval till date. UK Bahrain Canada Mexico US Singapore Oman...

3 Dec 2020

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Posted Byadmin

Comments0

TagsBioNTech, Covid vaccine, pfizer

The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner...

2 Dec 2020

Saudi Arabia signs non-binding vaccine agreement with CureVac

Posted Byadmin

Comments0

TagsCovid vaccine, COVID-19, CureVac

Saudi Arabia’s Pharmaceutical Industries and Medical supplies Corporation (Spimaco) signed a non-binding agreement with CureVac. CureVac is a German pharmaceutical...

1 Dec 2020

Telix Pharma to acquire TheraPharm GmbH

Posted Byadmin

Comments0

TagsScintec, TheraPharm GmbH

Telix Pharmaceuticals announced that it has entered into an agreement with Scintec Diagnostics GmbH (Scintec) to acquire TheraPharm GmbH, a...

28 Nov 2020

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Posted Byadmin

Comments0

Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo (roxadustat) for...

28 Nov 2020

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

Posted Byadmin

Comments0

More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development...

28 Nov 2020

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

Posted Byadmin

Comments0

Tagscodevelopment deal in pharma, Drug development, drug development project

Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and...

28 Nov 2020

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Posted Byadmin

Comments0

Tags2015 sales of Humira, humira, pyoderma gangrenosum

AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody,...

20 Nov 2020

Pfizer submitted application for emergency use of Covid vaccine

Posted Byadmin

Comments0

TagsCovid vaccine, COVID-19, vaccine

US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the...

20 Nov 2020

Take Self Competency Test in Esxport Documentation

Posted Byadmin

Comments0

Tagsmcqs in pharma export documentation

You can take a short and quick competency test on pharmaceutical export.

20 Nov 2020

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

Posted Byadmin

Comments0

TagsChronic Kidney Disease, CKD, Fresenius Kabi, Hyperkalemia, Veltassa, VFMCRP, Vifor Pharma

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for...

20 Nov 2020

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Posted Byadmin

Comments0

Tagsavalglucosidase alfa, Biological License Application, biological products, priority review, Priority Review Designation, USFDA Priority Review

The US Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa...

30 Oct 2020

Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning

Posted Byadmin

Comments0

Tagsgilead, Gilead Sciences, pharma strategic deal, Remdesivir, Strategic deal in pharma, strategic management in pharma, Veklury

FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years...

30 Oct 2020

Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda

Posted Byadmin

Comments0

TagsKEYTRUDA, MSD, Phase 2 trial, Sanofi

Sanofi has entered into an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the US...

30 Oct 2020

MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine

Posted Byadmin

Comments0

TagsCOVID-19, EU drug regulatory affairs, Moderna Therapeutics, nCoV-19 vaccine, vaccine

Moderna, a biotechnology company, announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has started...

Recently Published Articles

DCGI – India approved anti-Covid drug 2-DG developed by DRDO for emergency use

Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India

Case Study: Pfizer acquires Amplyx Pharmaceuticals

Philips acquired US-based remote medical technology company, BioTelemetry

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Sanofi received additional indication approval for Plavix

CoronaVac received conditional marketing authorization from NMPA China

What is the meaning of pharmaceutical profiling?

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Covishield received emergency use authorization in India

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

Insight on Aurobindo and COVAXX exclusive licensing agreement

Pfizer, BioNTech covid vaccine approval tilldate

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Saudi Arabia signs non-binding vaccine agreement with CureVac

Telix Pharma to acquire TheraPharm GmbH

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Pfizer submitted application for emergency use of Covid vaccine

Take Self Competency Test in Esxport Documentation

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning

Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda

MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine

Your form has been submitted